The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5-chloro-2-(4-(4-methoxyphenylsulfonamido)-3-methylphenylamino)pyrimidin-4-ylamino)-N-methylbenzamide ID: ALA4095740
PubChem CID: 137655244
Max Phase: Preclinical
Molecular Formula: C26H25ClN6O4S
Molecular Weight: 553.04
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)c3ccc(OC)cc3)c(C)c2)ncc1Cl
Standard InChI: InChI=1S/C26H25ClN6O4S/c1-16-14-17(8-13-22(16)33-38(35,36)19-11-9-18(37-3)10-12-19)30-26-29-15-21(27)24(32-26)31-23-7-5-4-6-20(23)25(34)28-2/h4-15,33H,1-3H3,(H,28,34)(H2,29,30,31,32)
Standard InChI Key: YTMWTPOFVBPCRU-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
24.9574 -6.1207 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5529 -5.4149 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.1439 -6.1181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.9712 -0.5117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9701 -1.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6781 -1.7402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3878 -1.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3850 -0.5081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6763 -0.1029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2621 -1.7393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0961 -1.7383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2614 -2.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5533 -2.9630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5523 -3.7794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2602 -4.1894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9706 -3.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9681 -2.9619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0974 -2.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3891 -2.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3900 -3.7800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0989 -4.1884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8083 -3.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8039 -2.9592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0911 -0.0969 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.5095 -2.5471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2193 -2.9522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5055 -1.7299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9249 -2.5401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2606 -5.0066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8452 -5.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8497 -4.1901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1426 -3.7820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4342 -4.1910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4373 -5.0124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1449 -5.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7257 -3.7837 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0188 -4.1936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6794 -4.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
7 11 1 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
8 24 1 0
23 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
15 29 1 0
29 2 1 0
2 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
33 36 1 0
36 37 1 0
16 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 553.04Molecular Weight (Monoisotopic): 552.1347AlogP: 5.09#Rotatable Bonds: 9Polar Surface Area: 134.34Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.57CX Basic pKa: 2.90CX LogP: 6.02CX LogD: 6.00Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.23Np Likeness Score: -1.82
References 1. Qu M, Liu Z, Zhao D, Wang C, Zhang J, Tang Z, Liu K, Shu X, Yuan H, Ma X.. (2017) Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity., 25 (15): [PMID:28576633 ] [10.1016/j.bmc.2017.05.044 ]